A collaboration between McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) and MD Anderson Cancer Center

Nivedita Thakur, MD; John M. Slopis, MD; Mary Kay Koenig, M.D.

Mission

  • Provide cutting edge medical care to individuals affected by AT
  • Perform state-of-the art research addressing the most critical and pertinent questions regarding the mechanisms of neurological dysfunction in Ataxia-Telangiectasia (AT)
  • Translate basic science research findings into clinical therapies
  • Educate medical professionals and the community about AT

Focus

  • Primary and sub-specialty physicians working collaboratively to provide complete medical care for AT patients thus improving overall health and quality of life for AT patients
  • The AT research center will spearhead a focused effort in performing basic and translational research aimed at treating the neurological outcomes of AT, which currently remain untreatable
  • Enhance the already excellent reputation of both the medical school and the hospital by attracting patients from both a local and national patient pool
  • Obtain basic science and clinical research funding. Research grants will enhance the research reputation of both institutions and also provide overhead.
  • Provide outstanding and unique opportunities for teaching graduate students, medical students, residents, and fellows.

Locations

  • Clinical Outpatient Service
    • University of Texas Professional Building
    • MD Anderson Outpatient Clinic
  • Clinical Inpatient Service
    • Memorial Hermann Health Care System
    • MD Anderson Cancer Center

Dedicated UT Ataxia-Telangiectasia Center Staff

Nivedita Thakur, MD, Clinical Co-Director
John Slopis, MD, Clinical Co-Director
Mary Kay Koenig, PhD, Research Director
Rahmat Adejumo, MBBS, MPH, Research Coordinator